A Study of Awareness and Education in Uterine Fibroids

Overview

About this study

The purpose of this study is increase early awareness of symptoms suggestive of fibroids and increase knowledge surrounding the range of treatment options. 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Group 1 (non-symptomatic) Inclusion Criteria:

  • Identifies as female at birth
  • Identifies as BAA,
  • No diagnosis of fibroids,
  • age 18 - 44 at the time of the focus group,

Group 2 (symptomatic) Inclusion Criteria:

  • Identifies as female at birth
  • Identifies as BAA
  • Diagnosis of fibroids,
  • age 18 - 44 at the time of the focus group,

Exclusion Criteria: 

  • Does not meet inclusion criteria and does not speak or understand English.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 5/22/2024. Questions regarding updates should be directed to the study team contact.

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Elizabeth Stewart, M.D.

Contact us for the latest status

Contact information:

Kirsten Riggan M.S., M.A.

(507) 284-2046

Riggan.Kirsten@mayo.edu

Jacksonville, Fla.

Mayo Clinic principal investigator

Megan Allyse, Ph.D.

Contact us for the latest status

Contact information:

Kirsten Riggan M.S., M.A.

(507) 284-2046

Riggan.Kirsten@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20572576

Mayo Clinic Footer